Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonreplacement operations for mitral valve regurgitation

C Hahn1, G J Vlahakes

  • 1Cardiac Surgical Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

Annual Review of Medicine
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two new dactylogyrid species (Platyhelminthes: <i>Monogenea</i>) parasitising the gills of <i>Garra gotyla</i> (Cyprinidae) in India: morphological and molecular characterization.

Journal of helminthology·2025
Same author

First insights into the ectoparasitic helminth fauna of freshwater fish on an Adriatic island.

Journal of helminthology·2025
Same author

Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned.

Annals of surgical oncology·2021
Same author

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).

BMC cancer·2019
Same author

Pure and Oxidized Copper Materials as Potential Antimicrobial Surfaces for Spaceflight Activities.

Astrobiology·2017

Mitral valve reconstruction is a viable alternative to replacement for severe mitral regurgitation, offering good long-term results. This approach avoids long-term anticoagulation and is increasingly favored for earlier disease intervention.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Repair
  • Medical Technology

Background:

  • Severe mitral regurgitation necessitates treatment, traditionally mitral valve replacement.
  • Surgical techniques for mitral valve repair have advanced significantly over 15 years.
  • Reconstruction addresses various anatomical causes of mitral regurgitation.

Purpose of the Study:

  • To highlight mitral valve reconstruction as an alternative to replacement.
  • To discuss the evolution of surgical techniques for mitral valve repair.
  • To emphasize the benefits of reconstruction for patients with mitral regurgitation.

Main Methods:

  • Review of evolving surgical techniques for mitral valve reconstruction.
  • Analysis of patient outcomes with nonreplacement therapy.

Related Experiment Videos

  • Assessment of the amenability of various mitral regurgitation etiologies to reconstruction.

    • Main Results:

    • Over 90% of regurgitant mitral valves are treatable with reconstruction.
    • Reconstruction demonstrates good intermediate- and long-term patient outcomes.
    • Mitral valve reconstruction eliminates the need for long-term anticoagulation.

    Conclusions:

    • Mitral valve reconstruction is a highly effective nonreplacement therapy for severe mitral regurgitation.
    • The trend is towards earlier reconstruction to prevent atrial fibrillation and ventricular dilatation.
    • Reconstruction offers a favorable alternative to valve replacement, improving patient management.